Experience

Lumosa Therapeutics Co., Ltd.

• Taiwan
• Biotechnology Research
• 1 - 100 Employee

• Head Of Business Development

  • Feb 2019 - 4 years 11 months

  Taiwan 1. Novel drugs out-license / co-development A. Stroke, Phase 2 B. Post-operative pain, on market C. Exosome, pre-clinical D. CAR-T, pre-clinical 2. Breakthrough technology in-license / investment / co-development / research collaboration



BAO PHARMA

• India
• Mining
• 1 - 100 Employee

• Business Development Consultant (Part of Center Lab Group)

  • Nov 2021 - 2 years 2 months

  Shanghai, China Novel drugs out-license / co-development A. IgG cleaving enzyme, Phase 1 B. Recombinant human hyaluronidase, registration



TOT BIOPHARM

• China
• Pharmaceutical Manufacturing
• 1 - 100 Employee

• Business Development Consultant (Part of Center Lab Group)

  • Jun 2020 - 3 years 7 months

  Taipei City, Taiwan Biosimilar drugs out-license A. Trastuzumab emtansine biosimilar, pre-clinical B. Bevacizumab biosimilar, on market



晟德大藥廠股份有限公司（TWO：4123）Center Laboratories, Inc.

• Taiwan
• Biotechnology Research
• 1 - 100 Employee

• Business Development Consultant (Part of Center Lab Group)

  • Nov 2019 - 4 years 2 months

  Taipei City, Taiwan New drug out-license Type 2 Diabetes



Mycenax Biotech Inc.

• Taiwan
• Biotechnology
• 1 - 100 Employee

• Business Development Consultant (Part of Center Lab Group)

  • Jul 2019 - Sep 2020

  Taipei City, Taiwan Biosimilar out-license (global deal closed) Tocilizumab biosimilar, Phase 3


SynCore Biotechnology Co., Ltd.
• Biotechnology Research
• 1 - 100 Employee
• Head Of Business Development

  • Jun 2014 - Feb 2019


Medigen Biotechnology Corp.

• Taiwan
• Biotechnology Research
• 1 - 100 Employee

• Key Account Sales Manager

  • Feb 2012 - Jun 2014

  Taiwan


Taipei Veterans General Hospital
• Taiwan
• Hospitals and Health Care
• 700 & Above Employee
• Research Assistant

  • 2007 - 2009